PhysioSpace: Relating Gene Expression Experiments from Heterogeneous Sources Using Shared Physiological Processes

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Lenz, Michael ^a   Schuldt, Bernhard M ^a   Müller, Franz Josef ^b   Schuppert, Andreas ^a,c  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b Zentrum fur Integrative Psychiatrie   (Germany)

^c BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER GRADING; CELL DIFFERENTIATION; DISEASE ASSOCIATION; DISEASE COURSE; EMBRYOID BODY; EMBRYONIC STEM CELL; GENE EXPRESSION SYSTEM; GENE FUNCTION; GENE MAPPING; GENE MUTATION; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC DATABASE; GENETIC HETEROGENEITY; GENETIC TRANSFORMATION; HUMAN; IN VITRO STUDY; MOLECULAR DYNAMICS; MOLECULAR MECHANICS; NERVE CELL DIFFERENTIATION; NUCLEOTIDE SEQUENCE; PHENOTYPE; PLURIPOTENT STEM CELL; QUALITATIVE ANALYSIS; SAMPLE SIZE; TIME SERIES ANALYSIS;

ALGORITHMS; CELL LINE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENOME-WIDE ASSOCIATION STUDY; HUMANS;

EID: 84885764376     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077627     Document Type: Article

References (50)

1. Schneider MV, Jimenez RC, (2012) Teaching the fundamentals of biological data integration using classroom games. PLOS Comput Biol 8(12):: e1002789. doi:10.1371/journal.pcbi.1002789. PubMed: 23300402.
2. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, et al. (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34(3):: 267-273. doi:10.1038/ng1180. PubMed: 12808457.
3. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550. doi:10.1073/pnas.0506580102. PubMed: 16199517.
4. Khatri P, Sirota M, Butte AJ, (2012) Ten years of pathway analysis: current approaches and outstanding challenges. PLOS Comput Biol 8: e1002375. PubMed: 22383865.
5. Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, et al. (2006) The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science (New York, NY) 313: 1929-1935. doi:10.1126/science.1132939. PubMed: 17008526.
6. Müller FJ, Schuldt BM, Williams R, Mason D, Altun G, et al. (2011) A bioinformatic assay for pluripotency in human cells. Nat Methods 8: 315-317. doi:10.1038/nmeth.1580. PubMed: 21378979.
7. Williams R, Schuldt B, Müller FJ, (2011) A guide to stem cell identification: progress and challenges in system-wide predictive testing with complex biomarkers. Bioessays 33: 880-890. doi:10.1002/bies.201100073. PubMed: 21901750.
8. Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, et al. (2012) The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483: 603-607. doi:10.1038/nature11003. PubMed: 22460905.
9. Shigemizu D, Hu Z, Hung JH, Huang CL, Wang Y, et al. (2012) Using functional signatures to identify repositioned drugs for breast, myelogenous leukemia and prostate cancer. PLOS Comput Biol 8: e1002347. doi:10.1371/journal.pcbi.1002347. PubMed: 22346740.
10. Yamanaka S, (2012) Induced pluripotent stem cells: past, present, and future. Cell Stem Cell 10: 678-684. doi:10.1016/j.stem.2012.05.005. PubMed: 22704507.
11. Müller FJ, Laurent LC, Kostka D, Ulitsky I, Williams R, et al. (2008) Regulatory networks define phenotypic classes of human stem cell lines. Nature 455: 401-405. doi:10.1038/nature07213. PubMed: 18724358.
12. Markert EK, Mizuno H, Vazquez A, Levine AJ, (2011) Molecular classification of prostate cancer using curated expression signatures. Proc Natl Acad Sci U S A 108: 21276-21281. doi:10.1073/pnas.1117029108. PubMed: 22123976.
13. Shats I, Gatza ML, Chang JT, Mori S, Wang J, et al. (2011) Using a stem cell-based signature to guide therapeutic selection in cancer. Cancer Res 71: 1772-1780. doi:10.1158/0008-5472.CAN-10-1735. PubMed: 21169407.
14. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, et al. (2008) An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40: 499-507. doi:10.1038/ng.127. PubMed: 18443585.
15. Zhang B, Chen B, Wu T, Xuan Z, Zhu X, et al. (2011) Estimating developmental states of tumors and normal tissues using a linear time-ordered model. BMC Bioinformatics 12: 53. doi:10.1186/1471-2105-12-53. PubMed: 21310084.
16. Venet D, Dumont JE, Detours V, (2011) Most random gene expression signatures are significantly associated with breast cancer outcome. PLOS Comput Biol 7: e1002240. PubMed: 22028643.
17. Starmans MHW, Krishnapuram B, Steck H, Horlings H, Nuyten DSA, et al. (2008) Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types. Br J Cancer 99: 1884-1890. doi:10.1038/sj.bjc.6604746. PubMed: 18985037.
18. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674. doi:10.1016/j.cell.2011.02.013. PubMed: 21376230.
19. Lukk M, Kapushesky M, Nikkilä J, Parkinson H, Goncalves A, et al. (2010) A global map of human gene expression. Nat Biotechnol 28: 322-324. doi:10.1038/nbt0410-322. PubMed: 20379172.
20. Zheng-Bradley X, Rung J, Parkinson H, Brazma A, (2010) Large scale comparison of global gene expression patterns in human and mouse. Genome Biol 11: R124. doi:10.1186/gb-2010-11-6-124. PubMed: 21182765.
21. Müller F-J, Schuppert A, (2011) Few inputs can reprogram biological networks. Nature 478: E4. doi:10.1038/nature10543. PubMed: 22012402.
22. Jiang Z, Gentleman R, (2007) Extensions to gene set enrichment. Bioinformatics (Oxf, England) 23: 306-313. doi:10.1093/bioinformatics/btl599. PubMed: 17127676.
23. Ackermann M, Strimmer K, (2009) A general modular framework for gene set enrichment analysis. BMC Bioinformatics 10: 47. doi:10.1186/1471-2105-10-S1-S47. PubMed: 19192285.
24. Nam D, (2010) De-correlating expression in gene-set analysis. Bioinformatics (Oxf, England) 26: i511-i516. doi:10.1093/bioinformatics/btq380. PubMed: 20823315.
25. Gower AC, Spira A, Lenburg ME, (2011) Discovering biological connections between experimental conditions based on common patterns of differential gene expression. BMC Bioinformatics 12: 381. doi:10.1186/1471-2105-12-381. PubMed: 21951600.
26. Kang HJ, Kawasawa YI, Cheng F, Zhu Y, Xu X, et al. (2011) Spatio-temporal transcriptome of the human brain. Nature 478: 483-489. doi:10.1038/nature10523. PubMed: 22031440.
27. Smyth GK, (2005) Limma: linear models for microarray data. In: Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W, eds., Bioinformatics and Computational Biology Solutions using R and Bioconductor. New York: Springer Verlag. pp. pp. 397-420.
28. Mizuno H, Spike BT, Wahl GM, Levine AJ, (2010) Inactivation of p53 in breast cancers correlates with stem cell transcriptional signatures. Proc Natl Acad Sci U S A 107: 22745-22750. doi:10.1073/pnas.1017001108. PubMed: 21149740.
29. Mosley JD, Keri RA, (2008) Cell cycle correlated genes dictate the prognostic power of breast cancer gene lists. BMC Med Genomics 1: 11. doi:10.1186/1755-8794-1-11. PubMed: 18439262.
30. Domagala-Kulawik J, (2008) Effects of cigarette smoke on the lung and systemic immunity. J Physiol Pharmacol 59: 19-34. PubMed: 19218630.
31. Staaf J, Jönsson G, Jönsson M, Karlsson A, Isaksson S, et al. (2012) Relation between smoking history and gene expression profiles in lung adenocarcinomas. BMC Med Genomics 5: 22. doi:10.1186/1755-8794-5-22. PubMed: 22676229.
32. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B Stat Methodol 57: 289-300.
33. Gatti DM, Barry WT, Nobel AB, Rusyn I, Wright FA, (2010) Heading down the wrong pathway: on the influence of correlation within gene sets. BMC Genomics 11: 574. doi:10.1186/1471-2164-11-574. PubMed: 20955544.
34. Inoue H, Yamanaka S, (2011) The use of induced pluripotent stem cells in drug development. Clin Pharmacol Ther 89: 655-661. doi:10.1038/clpt.2011.38. PubMed: 21430656.
35. Wu SM, Hochedlinger K, (2011). arnessing Potential Induced Pluripotent Stem Cells Regen Med. 13: 497-505.
36. Keller G, (2005) Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev 19: 1129-1155. doi:10.1101/gad.1303605. PubMed: 15905405.
37. Marchand M, Horcajadas JA, Esteban FJ, McElroy SL, Fisher SJ, et al. (2011) Transcriptomic signature of trophoblast differentiation in a human embryonic stem cell model. Biol Reprod 84: 1258-1271. doi:10.1095/biolreprod.110.086413. PubMed: 21368299.
38. Shi L, Campbell G, Jones WD, Campagne F, Wen Z, et al. (2010) The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol, 28: 827-838. doi:10.1038/nbt.1665. PubMed: 20676074.
39. Schneckener S, Arden NS, Schuppert A, (2011) Quantifying stability in gene list ranking across microarray derived clinical biomarkers. BMC Med Genomics 4: 73. doi:10.1186/1755-8794-4-73. PubMed: 21996057.
40. Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, et al. (2010) Integrative genomic profiling of human prostate cancer. Cancer Cell, 13: 11-22. PubMed: 20579941.
41. Sboner A, Demichelis F, Calza S, Pawitan Y, Setlur SR, et al. (2010) Molecular sampling of prostate cancer: a dilemma for predicting disease progression. BMC Med Genomics 3: 8. doi:10.1186/1755-8794-3-8. PubMed: 20233430.
42. Bock C, Kiskinis E, Verstappen G, Gu H, Boulting G, et al. (2011) Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 144: 439-452. doi:10.1016/j.cell.2010.12.032. PubMed: 21295703.
43. MacArthur BD, Sevilla A, Lenz M, Müller FJ, Schuldt BM, et al. (2012) Nanog-dependent feedback loops regulate murine embryonic stem cell heterogeneity. Nat Cell Biol 14: 1139-1147. doi:10.1038/ncb2603. PubMed: 23103910.
44. Shao K, Koch C, Gupta MK, Lin Q, Lenz M, et al. (2013) Induced pluripotent mesenchymal stromal cell clones retain donor-derived differences in DNA methylation profiles. Molecular Therapy 21: 240-250. doi:10.1038/mt.2012.207. PubMed: 23032973.
45. Oshlack A, Wakefield MJ, (2009) Transcript length bias in RNA-seq data confounds systems biology. Biol Direct 4(14):: 14-. doi:10.1186/1745-6150-4-14. PubMed: 19371405.
46. Young MD, Wakefield MJ, Smyth GK, Oshlack A, (2010) Gene ontology analysis for RNA-seq: accounting for selection bias. Genome Biol 11: R14. doi:10.1186/gb-2010-11-2-r14. PubMed: 20132535.
47. Edgar R, Domrachev M, Lash AE, (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210. doi:10.1093/nar/30.1.207. PubMed: 11752295.
48. Parkinson H, Kapushesky M, Kolesnikov N, Rustici G, Shojatalab M, et al. (2009) ArrayExpress update-from an archive of functional genomics experiments to the atlas of gene expression. Nucleic Acids Res. doi:10.1093/nar/gkn889.
49. Durinck S, Spellman PT, Birney E, Huber W, (2009) Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt. Nat Protoc 4: 1184-1191. doi:10.1038/nprot.2009.97. PubMed: 19617889.
50. R Development Core Team (2011) R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. ISBN 3-900051-07-0. Available: http://www.R-project.org/. Accessed 2013 September 27.